SkinHealth Systems Inc. (SKIN) Earnings Call Transcripts
SkinHealth Systems Inc.'s Latest Earnings Call - Q1 FY2026
In the first quarter of 2026, SkinHealth Systems Inc. (SKIN:US) reported net sales of $64.9 million and adjusted EBITDA of $8.5 million, reflecting a 17% year-over-year increase. However, the company revised its full-year revenue guidance down to a range of $280 million to $295 million, a reduction of approximately 2.5% from previous estimates, due to ongoing softness in capital equipment demand and longer purchasing cycles. Despite the revenue outlook downgrade, management maintained its adjusted EBITDA guidance of $35 million to $45 million, indicating strong operational discipline and margin resilience.
Reported metrics
| Metric | Value |
|---|---|
| Net Sales | $64.9 million (inline) |
| Adjusted EBITDA | $8.5 million (beat) |
| Consumables Revenue | $46.4 million (miss) |
| Active Installed Base | 36,400 devices (positive) |
| Adjusted Gross Margin | 72.2% (positive) |
| Net Loss | $6.6 million (positive) |
Guidance from management
Management maintained its adjusted EBITDA guidance of $35 million to $45 million for the year, indicating confidence in operational strength despite the revenue outlook downgrade.
What management said
No, we're not seeing anything specific, Bruce, on overall increases in our prices. On the capital equipment side, we have a decent amount of raw materials already in-house. We've been working through our existing inventory. So we shouldn't see an impact of that in the near term. So overall, I'm not concerned about inflation materially impacting the adjusted EBITDA guide.
What analysts pressed on
Analysts expressed concerns regarding the impact of macroeconomic conditions on consumer spending and the competitive landscape, particularly the rise of lower-cost alternatives in the market. There were also questions about the timing of expected improvements in revenue growth and device placements.
Main topics on the call
- Revenue Guidance Revision — Management revised the full-year revenue outlook to $280 million to $295 million, down from $285 million to $305 million, citing 'continued softness in capital equipment demand' and the time required for commercial initi...
- Adjusted EBITDA Performance — Adjusted EBITDA for Q1 was $8.5 million, exceeding the high end of guidance by a significant margin. This performance was attributed to 'operational discipline and margin strength' despite lower revenue.
- Installed Base Growth — The active installed base grew to 36,400 devices, a 4% increase year-over-year, with device churn declining 40% year-over-year, indicating improved provider retention and reactivation efforts.
- Consumables Revenue Decline — Consumables revenue was $46.4 million, down 6.1% year-over-year, primarily due to the transition to a distributor model in China. Management expects this decline to normalize over time.
Read the full SkinHealth Systems Inc. transcript (Q1 FY2026) → Summary generated from the call transcript; every figure above is stated by management on the record.
About SkinHealth Systems Inc.
SkinHealth Systems Inc. (SKIN) is a publicly listed company in the Personal Care Products industry, within the Consumer Staples sector. It trades on NasdaqCM and is based in US. EarningsCalls.dev maintains a free, full-text archive of its earnings call transcripts — 27 calls on record spanning December 9, 2020 to August 6, 2026. Every transcript is split into speaker-by-speaker segments with headline metrics, free to read or available through our REST API.
Earnings Call History
EarningsCalls.dev has 27 SkinHealth Systems Inc. earnings call transcripts on record, spanning December 9, 2020 to August 6, 2026. Based on this history, SkinHealth Systems Inc. reports quarterly. The most recent call on file is dated August 6, 2026. The full list is below — each row opens the complete, free-to-read transcript.
- Ticker
- SKIN
- Exchange
- NasdaqCM
- Country
- US
- Sector
- Consumer Staples
- Industry
- Personal Care Products
- Calls on record
- 27
- First call
- December 9, 2020
- Most recent
- August 6, 2026
- Reporting cadence
- quarterly